Nephro Care India Ltd
Fri 4/09/2026,15:32:0 | NSE : NEPHROCARE
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 98.00
Previous Close
₹ 98.00
Volume
26800
Mkt Cap ( ₹ Cr)
₹ 154.23
High
₹ 98.50
Low
₹ 89.95
52 Week High
₹ 173.95
52 Week Low
₹ 50.05
Book Value Per Share
₹ 35.46
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Nephro Care India Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Nephro Care India Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Nephro Care India - Reply to Clarification- Financial results
-
Nephro Care India - Clarification - Financial Results
-
Nephro Care India - Record Date
-
Nephro Care India - Updates
-
Nephro Care India - Shareholders meeting
-
Nephro Care India - Outcome of Board Meeting
-
Nephro Care India - Statement of deviation(s) or variation(s) under Reg. 32
-
Nephro Care India - Outcome of Board Meeting
-
Nephro Care India has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Nephro Care India - Structural Digital Database
-
Nephro Care India - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
-
Nephro Care India - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Nephro Care India - Reply to Clarification- Financial results
-
Nephro Care India - Structural Digital Database
-
Nephro Care India - Clarification - Financial Results
-
Nephro Care India - Trading Window
Key fundamentals
Evaluate the intrinsic value of Nephro Care India Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 56.8535 | 53.4845 | 15.0253 | 4.9015 | 3.0326 |
| Liabilities | 56.8535 | 53.4845 | 15.0253 | 4.9015 | 3.0326 |
| Equity | 16.4864 | 16.4864 | 11.9024 | 0.5 | 0.5 |
| Gross Profit | 8.3234 | 5.8726 | 6.4661 | 3.6453 | 0.1256 |
| Net Profit | 3.369 | 3.6389 | 4.4114 | 1.9424 | -0.0098 |
| Cash From Operating Activities | 2.2107 | 7.8242 | 0.9108 | 4.3081 | 0.6173 |
| NPM(%) | 3.79 | 7.9 | 16.2 | 11.36 | -0.28 |
| Revenue | 88.7348 | 46.0311 | 27.2308 | 17.0927 | 3.4244 |
| Expenses | 80.4114 | 40.1585 | 20.7647 | 13.4474 | 3.2988 |
| ROE(%) | 5.76 | 6.22 | 7.54 | 3.32 | -0.01 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Nephro Care India Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 860.25 | -1.14 | 21.76 | 0.00 | -26.19 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 109.43 | 0.14 | 1563.29 | 0.00 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 8.32 | -0.48 | 26.00 | 0.00 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 554.45 | -3.28 | 0.00 | 0.00 | -363.14 | 0.00 |
Company Info
Our Company was originally incorporated on July 08, 2014 as a Private Limited Company as "Nephro Care India Private Limited" under the provisions of the Companies Act, 2013 with the Registrar of Companies, West Bengal. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our Shareholders at an extraordinary general meeting held on December 26, 2023 and consequently the name of our Company was changed to `Nephro Care India Limited' and a fresh certificate of incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. The corporate identification number of our Company is U85100WB2014PLC202429.Major Events and Milestones:2014Incorporated as Nephro Care India Private Limited2021Commencement of our flagship Salt Lake, Kolkata clinic2023Commencement of two satellite clinics at Chandannagar< West Bengal2024Converted into Nephro Care India Limited
Our Company was originally incorporated on July 08, 2014 as a Private Limited Company as "Nephro Care India Private Limited" under the provisions of the Companies Act, 2013 with the Registrar of Companies, West Bengal. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our Shareholders at an extraordinary general meeting held on December 26, 2023 and consequently the name of our Company was changed to `Nephro Care India Limited' and a fresh certificate of incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. The corporate identification number of our Company is U85100WB2014PLC202429.Major Events and Milestones:2014Incorporated as Nephro Care India Private Limited2021Commencement of our flagship Salt Lake, Kolkata clinic2023Commencement of two satellite clinics at Chandannagar< West Bengal2024Converted into Nephro Care India Limited
Read More
Parent Organisation
Nephro Care India Ltd.
Founded
08/07/2014
Managing Director
Dr.Pratim Sengupta
NSE Symbol
NEPHROCARESM
FAQ
The current price of Nephro Care India Ltd is
The 52-week high for Nephro Care India Ltd is
The market capitalization of Nephro Care India Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Nephro Care India Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Nephro Care India Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Nephro Care India Ltd shares.
The CEO of Nephro Care India Ltd is Dr.Pratim Sengupta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
